Projects

scientist
RNDr. Norbert Vrbjar, CSc.

International

Finished
  • Biocatalytic development of novel hybrid molecules with improved cardioprotective properties: Targeting the Na+,K+-ATPase
    Program: Inter-governmental agreement
    Duration: 1. 1. 2013 – 31. 12. 2014

National

Current
  • -
    Program: VEGA
    Duration: 1. 1. 2021 – 31. 12. 2024
  • The role of miRNAs in the onset and progression of cardiovascular diseases - new approach to the protection of the heart in situations of increased production of reactive oxygen species
    Program: SRDA
    Duration: 1. 7. 2020 – 30. 6. 2024
Finished
  • Heart protection in situations of excessive formation of oxygen and nitrosyl radicals: Molecular hydrogen as a new potential therapeutic tool?
    Program: VEGA
    Duration: 1. 1. 2018 – 31. 12. 2021
  • Properties of the Na,K-ATPase, representing one of the crucial systems in maintaining the sodium homeostasis in the organism, after irradiation.
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Response of the Na,K-ATPase, representing one of the crucial systems in maintaining the sodium homeostasis, to civilization diseases namely: hypertension, diabetes and hypertriglyceridemia.
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Sex differences in etiopathogenesis of social stress-related cardiovascular and behavioral disorders in individuals with predisposition to hypertension.
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Calcium channels in neuronal excitability
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 10. 2014
  • Gender differences in etiopathogenesis of social stress-related cardiovascular and behavioral disorders in individuals with predisposition to hypertension
    Program: SRDA
    Duration: 1. 5. 2011 – 30. 10. 2014
  • Regulation of homeostasis of sodium and potassium ions in normal and pathphysiological conditions.
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Gender specific adaptation of cardiac and renal Na,K-ATPase to hypertension and diabetes
    Program: VEGA
    Duration: 1. 1. 2007 – 1. 12. 2009
  • Protection of the heart against malignant arrhythmias and heart failure.
    Program: SRDA
    Duration: 2. 5. 2006 – 30. 4. 2009
Employees